Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A Antibodies.
期刊:Gastro Hep Advances
影响因子:0.000
doi:10.1016/j.gastha.2025.100778
Sugiyama Gen, Nio Kouki, Okada Hikari, Kida Akihiko, Sako Keisuke, Iwata Yasunori, Takayama Hideo, Kawakami Yutaro, Chiba Tomoyoshi, Nagai Kazuki, Sugimoto Saiho, Nishitani Masaki, Hayashi Tomoyuki, Takatori Hajime, Shimakami Tetsuro, Honda Masao, Yamashita Taro